Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Chemo-Enzymatic Manufacturing Routes to High- Value compounds

Objective

The aim of this project is to bring together subject matter experts from the academic and non-academic sectors to develop a platform of “green” chemoenzymatic methods for the production of high value active pharmaceutical ingredients – both those currently on the market, and those in development pipelines of the Pharma industry. The partners will exemplify the use of the platform through its application in the production of 4 drugs currently on the market – namely Duloxetine, Atomexetine, Ramosetron and Paricalcitol.
In order to achieve this objective the proposal brings together 3 partners with complementary skills:
Kelada Pharmachem: Phase transfer catalysis/organo catalysis/scale-up of chemical processes
Cerbios Pharma: Biocatalysis and fermentation methodologies for drug production
IC-CNR: Protein crystallography and enzymatic engineering

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-RISE-2014

See all projects funded under this call

Coordinator

CONSIGLIO NAZIONALE DELLE RICERCHE
Net EU contribution
€ 162 000,00
Address
PIAZZALE ALDO MORO 7
00185 Roma
Italy
Region
Centro (IT) Lazio Roma
Activity type
Research Organisations
Links
Total cost
€ 162 000,00

Participants (1)

Partners (1)